We need you! Join our contributor community and become a WikEM editor through our open and transparent promotion process.
Methotrexate
From WikEM
Contents
Administration
- Type: Immunosuppressant/antineoplastic
- Dosage Forms:
- Routes of Administration: IV/IM, oral
- Common Trade Names:
Adult Dosing
Ectopic pregnancy
- Single-dose regimen: Methotrexate 50 mg/m2
Pediatric Dosing
Special Populations
- Pregnancy Rating: X
- Lactation risk: Infant risk has been determined (risk of serious adverse effects for infant)
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
- Breastfeeding, pregnant, or possibility of impregnating someone
- Blood dyscrasias
- Chronic liver disease
Adverse Reactions
Serious
- Hepatotoxicity
- Nephrotoxicity
- Myelosuppression, aplastic anemia, pancytopenia
- Infectious disease
- Tumor lysis syndrome
- GI bleed
- Neurotoxicity, seizure
- Pericardial effusion
- TEN
Common
- Nausea/vomiting, diarrhea
- Stomatitis
- Leukopenia, thrombocytopenia
- Alopecia, photosensitivity, rash
- Dizziness
Pharmacology
- Half-life: 8-15hr
- Metabolism: Extensive hepatic and intracellular
- Excretion: Mostly renal. Dialyzable.
Mechanism of Action
- Inhibits dihydrofolate reductase→ blocks DNA synthesis and thus, cellular replication/repair
